NASDAQ:AKBA

Akebia Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy AKBA

*Your capital is at risk

$0.97

+0.0333 (+3.56%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

AKBA Prediction Chart

AKBA Predictions History

Latest community submissions for AKBA.

Predictor	Target Session	Target Price	Result	Direction	Accuracy
NameNotImportant Pro	Apr 29, 2019	$6.05 -4.12%	$6.31	X	95.88%
JuanC Villegas Pro	Aug 25, 2017	$16.09 -2.13%	$16.44	X	97.90%
JS Pro	May 16, 2017	$13.00 -13.39%	$15.01	X	86.60%

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AKBA with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT AKEBIA THERAPEUTICS

Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent and non-dialysis dependent adult patients. It also offers Auryxia, a ferric citra...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by